The drug approval—and an associated approval by the FDA's Center for Veterinary ... CS Vaccine R&D at multinationals, such as Paris-based Sanofi-aventis, GlaxoSmithKline (GSK), Merck and Wyeth ...

Dr Julie Louise Gerberding was the first woman to serve as director of the Centers for Disease Control, as well as leading the vaccine division at Merck for ... Roche vet joins two boards.

Merck & Co., Inc. operates as a healthcare company worldwide ... The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management ...

Merck's consistent dividend payments over 34 years, healthy balance sheet, and attractive valuation highlight its investment ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In October, Merck took up an option on the personalised RNA-based cancer vaccine with an upfront payment of $250 million as part of a collaboration first agreed in 2016 and expanded in 2018.

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...

and Merck and Co. (NYSE: MRK) can hold value during recessions. As the healthcare market hit lows during the coronavirus scare, these blue-chip companies brought hope for a vaccine from Gilead ...